Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/30/1998 | EP0867509A2 Tumor necrosis related receptor, TR5 |
09/30/1998 | EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor |
09/30/1998 | EP0867436A1 N-aryl-piperidine derivatives and their use as 5-HT1B receptor ligands |
09/30/1998 | EP0867430A2 Glutamic acid derivatives and pharmaceutical compositions for the treatment of central nervous system disorders |
09/30/1998 | EP0867192A2 Combinatory compositions for the treatment of dementia containing at least a compound having acetylcholinesterase-inhibitory or muscarinic activity and a compound that enhances the endogenous extracellular adenosine levels |
09/30/1998 | EP0867184A1 Use of tiagabine for the treatment of sleep disorders |
09/30/1998 | EP0867179A1 Composition of L-DOPA esters |
09/30/1998 | EP0867178A1 Non-allosteric GABA A agonists for treating sleep disorders |
09/30/1998 | EP0866790A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
09/30/1998 | EP0866719A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
09/30/1998 | EP0866713A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
09/30/1998 | EP0866706A1 Treatment of traumatic brain injury |
09/30/1998 | EP0866703A1 Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes |
09/30/1998 | EP0866702A1 Method for treating pain |
09/30/1998 | EP0866696A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
09/30/1998 | EP0866692A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock |
09/30/1998 | EP0866691A1 Sublingual and buccal administration of selegiline |
09/30/1998 | EP0866656A1 Inhibition of tumor necrosis factor alpha |
09/30/1998 | EP0828722A4 Process for making heterocyclic compounds |
09/30/1998 | CN1194646A Aza-Anthracyclinone derivatives |
09/30/1998 | CN1194643A Pyrrolyl tetrahydroquinoxalin diones, their production and use in treatment of diseases |
09/30/1998 | CN1040000C Process for preparing derivatives substituted in position 15 of 20, 21-dinoreburnamenine |
09/30/1998 | CN1039996C N-substituted azabicycloheptane devivatives and its use |
09/30/1998 | CN1039967C Preparing method for medecine composition comtaining ring substituted 2-amino-tetra hydronaphthalenes, 3-aminothiochromanes |
09/29/1998 | US5814654 Treatment of hypertension, arrhythmia, angina pectoris, cardiac hypertrophy, diabetes mellitus, organ disorders associated with ischemia, cerebro-ischemic disorders, cell proliferation, endothelial cell injury |
09/29/1998 | US5814512 Microorganism having all the identifying characteristics of absida ferm BP-4599 for producing purpurogallin derivatives |
09/29/1998 | CA2140012C Anxiolytic |
09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
09/25/1998 | CA2233077A1 Pharmaceutical compounds |
09/25/1998 | CA2232930A1 Oral application of (+)-o-demethyltramadol as a pain killing drug |
09/24/1998 | WO1998041639A1 Serine/threonine protein kinase |
09/24/1998 | WO1998041629A2 Death domain containing receptor 5 |
09/24/1998 | WO1998041625A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
09/24/1998 | WO1998041562A1 Non-antigenic branched polymer conjugates |
09/24/1998 | WO1998041538A2 Novel human cytokine/steroid receptor protein |
09/24/1998 | WO1998041528A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
09/24/1998 | WO1998041508A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
09/24/1998 | WO1998041507A1 Anti-convulsant isoquinolyl-benzamide derivatives |
09/24/1998 | WO1998041506A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
09/24/1998 | WO1998041242A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
09/24/1998 | WO1998041220A1 Mononuclear phagocytes and their use to promote axonal regeneration |
09/24/1998 | WO1998041201A1 Therapeutic compositions |
09/24/1998 | WO1998041200A1 Therapeutic compositions |
09/24/1998 | WO1998041092A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
09/24/1998 | DE19713434C1 Protein zur Inhibierung von Apoptose Protein for the inhibition of apoptosis |
09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
09/24/1998 | CA2284218A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
09/24/1998 | CA2284108A1 Novel human cytokine/steroid receptor protein |
09/24/1998 | CA2284035A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
09/24/1998 | CA2283891A1 Mononuclear phagocytes and their use to promote axonal regeneration |
09/24/1998 | CA2283688A1 Serine/threonine protein kinase |
09/24/1998 | CA2283682A1 Anti-convulsant isoquinolyl-benzamide derivatives |
09/24/1998 | CA2283438A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
09/24/1998 | CA2277179A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
09/23/1998 | EP0865789A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine |
09/23/1998 | EP0865429A1 Azetidinone compounds for the treatment of atherosclerosis |
09/23/1998 | EP0865428A1 Vitamin d analogues |
09/23/1998 | EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
09/23/1998 | EP0729469B1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS |
09/23/1998 | EP0700383B1 Novel 1-phenylalkanone 5-ht 4? receptor ligands |
09/23/1998 | EP0689535B1 Benzimidazole derivatives |
09/23/1998 | EP0680321B1 Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
09/23/1998 | CN1193974A £1,2,4| triazolo £4,3-1| quinoxalinone derivatives, their preparation and use |
09/23/1998 | CN1193973A £1,2,4| triazolo £4,3-a| quinoxalinone derivatives, their preparation and use |
09/23/1998 | CN1193968A 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
09/23/1998 | CN1193966A Aromatic compounds and pharmaceutical compositions containing them |
09/23/1998 | CN1193965A 10-acyloxy-10,11-dihydrodibenz/b, f/azepine-5-carboxamides useful for treating nervous system disorders |
09/23/1998 | CN1193964A Benzo£g| quinoline derivatives |
09/23/1998 | CN1193963A Aromatic compounds and pharmaceutical compositions containing them |
09/23/1998 | CN1193961A Substituted benzylaminopiperidine compounds |
09/23/1998 | CN1193516A Application of liver oil of globefish in preparation of medicines for drug dependence |
09/23/1998 | CN1039911C Galanthamine derivatives, a process for their preparation and use as medicaments |
09/23/1998 | CN1039910C Galanthamine derivatives, a process for their preparation and use as medicaments |
09/23/1998 | CN1039909C Aminobenzoic acid derivatives |
09/23/1998 | CN1039908C Tricyclic diazepine vasopressin antagonists |
09/23/1998 | CN1039906C Heteraryloxy-beta-carboline, process for its production and use in pharmaceutical agents |
09/22/1998 | US5811582 Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
09/22/1998 | US5811558 Process for the resolution of etodolac using glucamine derivatives |
09/22/1998 | US5811553 Quinoline derivatives(2) |
09/22/1998 | US5811549 Process of preparing imidazole compounds |
09/22/1998 | US5811520 Human phospholipase inhibitor protein |
09/22/1998 | US5811518 Polypeptide having specified amino acid sequence, capable of being specifically bound by antibody |
09/22/1998 | US5811459 Pain relievers |
09/22/1998 | US5811456 Treatment of alzheimer's disease |
09/22/1998 | US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders |
09/22/1998 | US5811436 Complexed with amberlite irp-88; administering to treat or prevent mixed anxiety and depression |
09/22/1998 | US5811435 2- (4-heteroaryl-1-piperidinyl)alkyl!-1,3-dioxanes and related compounds and their therapeutic utility |
09/22/1998 | US5811434 Methods and compositions for stimulating neurite growth |
09/22/1998 | US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia |
09/22/1998 | US5811430 1 (2-pyrimidinyloxy) alkyl!-4- (heteroaryl) Piperidines and related compounds and their therapeutic utility |
09/22/1998 | US5811400 Analgesics, immunosuppressive agents |
09/22/1998 | US5811245 Antibodies that specifically bind to ALK-7, a novel serine threonine kinase receptor |
09/22/1998 | US5811126 Mixtures of alginates, water-swellable macromolecules, edible hydrocarbon derivatives, divalent metal salts to crosslink the alginates and therapeutically active materials |
09/22/1998 | CA2135603C Solid dispersion compositions of tebufelone |
09/22/1998 | CA2131000C Indoles |
09/22/1998 | CA2115279C Pharmaceutical products with a content of dexpanthenol for topical applications |
09/22/1998 | CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present |